Natalizumab and progressive multifocal leukoencephalopathy - PubMed (original) (raw)

. 2005 Jul 28;353(4):432-3.

doi: 10.1056/NEJMc055235. Epub 2005 Jun 9.

• PMID: 15947083
• DOI: 10.1056/NEJMc055235

Natalizumab and progressive multifocal leukoencephalopathy

Burt Adelman et al. N Engl J Med. 2005.

No abstract available

PubMed Disclaimer

Similar articles

• Natalizumab for relapsing multiple sclerosis.
  Jeffery DR. Jeffery DR. N Engl J Med. 2006 Jun 1;354(22):2387-9; author reply 2387-9. N Engl J Med. 2006. PMID: 16742008 No abstract available.
• Natalizumab for relapsing multiple sclerosis.
  Meyer MA. Meyer MA. N Engl J Med. 2006 Jun 1;354(22):2387-9; author reply 2387-9. N Engl J Med. 2006. PMID: 16742009 No abstract available.
• Asymptomatic reactivation of JC virus in patients treated with natalizumab.
  Warnke C, Adams O, Kieseier BC. Warnke C, et al. N Engl J Med. 2009 Dec 17;361(25):2489; author reply 2489-90. N Engl J Med. 2009. PMID: 20050216 No abstract available.
• [New drugs; natalizumab].
  van Bronswijk H, Dubois EA, van Gerven JM, Cohen AF. van Bronswijk H, et al. Ned Tijdschr Geneeskd. 2008 Mar 1;152(9):499-500. Ned Tijdschr Geneeskd. 2008. PMID: 18389881 Review. Dutch.
• Multiple sclerosis, natalizumab therapy, and progressive multifocal leukoencephalopathy.
  Bartt RE. Bartt RE. Curr Opin Neurol. 2006 Aug;19(4):341-9. doi: 10.1097/01.wco.0000236612.66839.a2. Curr Opin Neurol. 2006. PMID: 16914971 Review.

Cited by

• The fundamental basis of inflammatory bowel disease.
  Strober W, Fuss I, Mannon P. Strober W, et al. J Clin Invest. 2007 Mar;117(3):514-21. doi: 10.1172/JCI30587. J Clin Invest. 2007. PMID: 17332878 Free PMC article. Review.
• Update on the management of Crohn's disease.
  Buchner AM, Blonski W, Lichtenstein GR. Buchner AM, et al. Curr Gastroenterol Rep. 2011 Oct;13(5):465-74. doi: 10.1007/s11894-011-0220-x. Curr Gastroenterol Rep. 2011. PMID: 21792543 Review.
• JC Virus infected choroid plexus epithelial cells produce extracellular vesicles that infect glial cells independently of the virus attachment receptor.
  O'Hara BA, Morris-Love J, Gee GV, Haley SA, Atwood WJ. O'Hara BA, et al. PLoS Pathog. 2020 Mar 4;16(3):e1008371. doi: 10.1371/journal.ppat.1008371. eCollection 2020 Mar. PLoS Pathog. 2020. PMID: 32130281 Free PMC article.
• Developing therapeutics for the treatment of multiple sclerosis.
  Virley DJ. Virley DJ. NeuroRx. 2005 Oct;2(4):638-49. doi: 10.1602/neurorx.2.4.638. NeuroRx. 2005. PMID: 16489371 Free PMC article. Review.
• Protecting axonal degeneration by increasing nicotinamide adenine dinucleotide levels in experimental autoimmune encephalomyelitis models.
  Kaneko S, Wang J, Kaneko M, Yiu G, Hurrell JM, Chitnis T, Khoury SJ, He Z. Kaneko S, et al. J Neurosci. 2006 Sep 20;26(38):9794-804. doi: 10.1523/JNEUROSCI.2116-06.2006. J Neurosci. 2006. PMID: 16988050 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Atypon
  • Ovid Technologies, Inc.

• Medical

  • MedlinePlus Health Information